Added to YB: 2025-09-08
Pitch date: 2025-09-04
BIM.PA [neutral]
bioMérieux S.A.
-8.46%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
bioMérieux S.A. develops and markets in vitro diagnostic solutions for infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
Market Cap
EUR 13.9B
Pitch Price
EUR 117.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
13.55
P/E
37.19
EV/Sales
3.40
Sector
Health Care Equipment and Supplies
Category
growth
bioMérieux (BIM France): cash and margins do the talking as guidance tilts to higher profit
BIM.PA (quick overview): H1 revenue growth slowed but cEBIT margin expanded >18%, FCF surged to €170M vs €50M prior year. Management raised EBIT guidance despite lowering revenue range. Strong NA performance, China drag persists. 2028 ~20% EBIT margin target looks achievable as co proves it can grow while expanding margins & generating cash.
Read full article (2 min)